Evaluation of the Federal 340B Drug Pricing Program

Monday, June 11, 2018: 1:30 PM-3:00 PM
1000 - First Floor (Rollins School of Public Health)
Organizer:
Jeah (Kyoungrae) Jung
1:30 PM
Consequences of the 340B Drug Pricing Program

Author(s): Sunita Desai; J. Michael McWilliams

Discussant: Abby Alpert
1:50 PM
A Prescription for Manipulation? Impact of the 340B Drug Discount Program on Hospitals

Author(s): Sayeh S. Nikpay; Melinda B. Buntin; Rena Conti

Discussant: David E. Tawes
2:10 PM
The Impact of a Federal Drug Pricing Program on Cancer Care Site and Spending in Medicare

Author(s): Jeah (Kyoungrae) Jung; Wendy Xu; Yamini Kalindindi

Discussant: Bingxiao Wu
See more of: Prescription Drugs
<< Previous Session | Next Session >>

American Society of Health Economists (ASHEcon)

1100 Vermont Avenue NW Suite 650

Washington, DC 20005

P: (202) 737 6608

F: (202) 496 0134

Copyright © 2017 ASHEcon - All rights reserved.